期刊文献+

两性霉素B及其卵磷脂-胆固醇脂质体降解动力学研究 被引量:4

Studies on degradation kinetics of amphotericin B in solution and liposome composed by egg phospholipid and cholesterol
下载PDF
导出
摘要 目的考察以卵磷脂、胆固醇为膜材制备的两性霉素B脂质体的稳定性及降解动力学。方法应用高效液相色谱法考察光和热对两性霉素B溶液及其脂质体中药物稳定性及降解动力学的影响,并拟合其降解动力学模型,求算降解半衰期。结果两性霉素B溶液及其脂质体光降解分别符合一级和零级动力学过程,降解半衰期分别为2.6和24.7d;热降解过程分别符合零级动力学和Higuchi方程;40℃下半衰期分别为27.8和1532.8d;60℃下半衰期分别为8.2和17.9d。结论脂质体可明显降低两性霉素B的光和热降解,延长药物降解半衰期,显著提高两性霉素B的稳定性。 Objective To study the stability and degradation kinetics of amphotericin B in liposome. Methods The light and thermal stabilities of amphotericin B in liposome and solution were determined by detecting its content using HPLC and the degradation kinetics was also investigated. Results The light degradation kinetics of amphotericin B in liposome and solution fit the zero- and first-order equations, and their half lives were 24.7d and 2.7d, respectively. While their thermal degradation kinetics complied with the Higuchi model and zero-order equations, respectively. The amphotericin B in liposome was more stable than that in solution at 40℃ and 60℃. The half lives of amphotericin B in liposome and solution were 1,532.8d and 27.8d at 40℃, but 17. 9d and 8.2d at 60℃, respectively. Conclusion The liposome can improve the light and thermal stabilities of amphotericin B significantly.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第8期486-489,495,共5页 Chinese Journal of Antibiotics
关键词 两性霉素B 卵磷脂 胆固醇 脂质体 稳定性 降解动力学 Amphotericin B Egg phospholipid Cholesterol Liposome Stability Kinetics equation
  • 引文网络
  • 相关文献

参考文献13

  • 1Hann I M,Prentice H G.Lipid-based amphotericin B:a review of the last 10 years of use[J].Intern J Antimicrob Agents,2001,17(3):161.
  • 2Jullien S,Contrepois A,Sligh J E.Study of the effects of liposomal amphotericin B on Candida albicans,Cryptococcus neoformans,and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids[J].Antimicrob Agents Chemother,1989,33 (3):345.
  • 3Lee J W,Amantea M A,Francis P A,et al.Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AMBisome) in rabbits[J].Antimicrob Agents Chemother,1994,38(4):713.
  • 4Walsh T J,Yeldandi V,Moevoy M,et al.Safety,tolerance,and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AMBisome) in neutropenic patients[J].Antimicrob Agents Chemother,1998,42(9):2391.
  • 5Berkersky I,Boswell G W,Hiles R,et al.Safety and toxicokinetics of intravenous liposomal amphotericin B (AM-bisome) in beagle dogs[J].Pharm Res,1999,16(11):1694.
  • 6Longuet P,Joly V,Amirault P,et al.Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats[J].Antimicrob Agents Chemother,1991,35(7):1303.
  • 7Moribe K,Maruyama K,Iwatsuru M.Molecular localization and state of amphotericin B in PEG liposomes[J].Intern J Pharmaceut,1999,193 (1):97.
  • 8张小滨,谢洁琼,侯新朴.不同表面活性剂对两性霉素B脂质体体内外性质的影响[J].药学学报,2003,38(6):471-474. 被引量:6
  • 9Brassinne C,Laduron C,Coune A,et al.High-performance liquid chromatographic determination of amphotericin B in human serum[J].J Chromatogr,1987,419(2):401.
  • 10Egger P,Bellmann R,Wiedermann C J.Determination of amphotericin B,liposomal amphotericin B,and amphotericin B colloidal dispersion in plasma by highperformance liquid chromatography[J].J Chromatogr B,2001,760(2):307.

二级参考文献3

共引文献5

同被引文献21

引证文献4

二级引证文献11

;
使用帮助 返回顶部